Should I Buy CTMX Stock in 2026?
Data-driven analysis and honest assessment for CytomX Therapeutics Inc
Current Price: $5.37P/E: 18.0
Decision Score
Weak
Based on 6 fundamental factors
Score Breakdown:
Reasonable P/E of 18.0
Declining -0%
Thin margins (0% net)
Financial health data limited
Low FCF yield of 1.9%
No recent insider activity
Key Investment Metrics
Current Price
$5.37
P/E Ratio
17.97
Revenue Growth
-0.8%
Profit Margin
0.2%
Market Cap
$0.9B
Dividend Yield
None
How CTMX Compares to Competitors
Understanding how CTMX stacks up against peers helps inform your investment decision.
How CTMX Compares to Peers
Upcoming Events for CTMX
+5 Reasons TO Buy CTMX
1. High gross margins of 100%
strongGross margins above 50% typically indicate strong brand value or intellectual property moats.
-5 Reasons NOT to Buy CTMX
1. Thin profit margins of 0.2%
high riskLow margins provide little cushion against cost increases or pricing pressure.
2. Revenue declining 1%
medium riskShrinking revenue suggests loss of market share or weakening demand. Turnarounds are difficult.
3. Small-cap volatility risk
medium riskMarket cap under $2B means higher volatility and lower liquidity.
4. Low free cash flow yield of 1.9%
low riskLimited cash generation means most value comes from future growth expectations.
Who Should Buy CTMX?
Investment Profile
Risk Level
Very High
Recommended Holding Period
3-5 years
Best For:
- ✓
Value Investors
P/E of 18.0 offers margin of safety
Not Suitable For:
- ✗
Growth Investors
Limited -1% growth may disappoint
- ✗
Income-Focused Retirees
No dividend paid
- ✗
Risk-Averse Investors
Very High risk may cause uncomfortable volatility
- ✗
Large Position Traders
Lower liquidity may impact execution
Consider These Alternatives
If you're interested in CTMX, compare these Healthcare peers:
Pro tip: Compare CTMX directly with competitors using our comparison tool to see which stock better fits your criteria.
Get the Full Picture
Access AI-powered insights, DCF valuations, insider trading data, and real-time analysis for CTMX
Frequently Asked Questions
What is CTMX stock price today?
CTMX (CytomX Therapeutics Inc) stock is trading at $5.37 as of the latest market data. Stock prices update in real-time during market hours (9:30 AM - 4:00 PM ET).
Is CTMX stock going up or down today?
CTMX stock price movements are influenced by market conditions, news, earnings reports, and investor sentiment. Check our live dashboard for real-time price changes and technical indicators.
Should I buy CTMX stock now?
The decision to buy CTMX depends on your investment strategy, risk tolerance, and financial goals. Our AI analysis evaluates fundamentals, valuation metrics, growth prospects, and market conditions to help inform your decision.
Is CTMX a buy, hold, or sell right now?
Our AI-powered analysis provides buy/hold/sell recommendations for CTMX based on multiple factors including valuation, growth metrics, technical indicators, and analyst consensus. Visit our dashboard for the latest recommendation.
Is CTMX stock overvalued or undervalued?
CTMX currently trades at a P/E ratio of 17.97 relative to earnings. Our DCF calculator provides intrinsic value estimates to help determine if CTMX is fairly priced.
What is CTMX's P/E ratio?
CTMX has a price-to-earnings (P/E) ratio of 17.97, which measures how much investors are willing to pay per dollar of earnings. Compare this to industry peers and historical averages for context.
What is CTMX's market cap?
CTMX (CytomX Therapeutics Inc) has a market capitalization of $0.91 billion, making it a small-cap stock.
What is CTMX's price to book ratio?
CTMX trades at a price-to-book (P/B) ratio of 8.50, which compares the stock price to the company's book value per share. A P/B below 1.0 may indicate undervaluation, while above 3.0 may suggest premium pricing.
Deep Dive Analysis
Explore comprehensive analysis tools to make an informed decision about CytomX Therapeutics Inc
Full Stock Analysis
Complete CTMX overview with charts and data
Is CTMX Undervalued?
DCF valuation and intrinsic value analysis
Dividend Analysis
Yield, payout ratio, and dividend history
Growth Analysis
Revenue, earnings, and expansion metrics
Financial Health
Debt, liquidity, and balance sheet strength
Price Prediction
2026 forecast and price targets
Stock Forecast
12-month price forecast and analyst targets
Earnings Date
Next earnings date and historical results
Compare Before You Buy
See how CTMX stacks up against its competitors
Similar Investment Decisions
Explore investment analyses for stocks similar to CytomX Therapeutics Inc
Complete CTMX Analysis
Compare CTMX With
Disclaimer
This analysis is for informational purposes only and should not be considered financial advice. The decision score and recommendations are based on quantitative factors and do not account for all risks, your personal financial situation, or qualitative factors. Always do your own research and consider consulting with a financial advisor before making investment decisions.